Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 13 Mar 2023
A new study by Sandra Amaral and her team has found that children with chronic kidney disease (CKD), regardless of disease severity,...
Read Full NewsIn a new trial, patients with PD-L1 CPS ≥ 1 HNSCC were randomly assigned 1:1 to receive 20 mg/d lenvatinib orally plus pembrolizumab 200 mg intravenously or placebo orally once daily plus pembrolizumab 200 mg intravenously.
The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.
1.
To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.
2.
According to JAMA, women who have false-positive mammogram results are at a higher risk of developing breast cancer over time.
3.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
4.
Study finds common genetic target may halt breast cancer cell growth
5.
A pilot study investigates a novel strategy for lowering anxiety and enhancing post-stem cell transplant quality of life.
1.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
2.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
3.
Everything You Need to Know About RDW-CV: A Comprehensive Guide
4.
Decoding the Padua Score to Prevent Blood Clots in High-Risk Patients
5.
Personalized Cancer Vaccines and Neoantigen mRNA: A New Era in Oncology
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XII
3.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
4.
Preventing Blood Clots: The Importance of Venous Thromboembolism Management
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge